Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1995
06/08/1995WO1995015308A1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine
06/08/1995WO1995015182A1 Antiinfective compositions and methods of use
06/08/1995WO1995015179A1 Method of treating intestinal disorders
06/08/1995WO1995015172A1 Extract from the leaves of gingko biloba
06/08/1995WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
06/08/1995WO1995015170A1 Use of dimeticone for treating constipation
06/08/1995WO1995015169A1 Use of dimeticone for treating aphthae and stomatitis
06/08/1995WO1995015167A1 In utero gene therapy for fetuses
06/08/1995WO1995015166A1 Use of aldosterone antagonists to inhibit myocardial fibrosis
06/08/1995WO1995015165A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri
06/08/1995WO1995015164A1 Use of theophylline for the manufacture of a medicament for the treatment of asthma
06/08/1995WO1995015163A1 Novel compounds for inhibition of cyclooxygenase activity
06/08/1995WO1995015162A1 Tablet or capsule containing a stable type 1 ranitidine hydrochloride
06/08/1995WO1995015161A2 Medicament for treating heart insufficiency
06/08/1995WO1995015160A1 Use of selegiline and its derivatives for the treatment of psoriasis
06/08/1995WO1995015159A1 Inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient
06/08/1995WO1995015155A1 Taste masked composition containing a drug/polymer complex
06/08/1995WO1995015151A1 Aerosol drug formulations for use with non-cfc propellants
06/08/1995WO1995015149A1 Novel cosmetic compositions containing simple polyols
06/08/1995WO1995015148A1 Topical preparations containing l-arginine
06/08/1995WO1995015147A1 Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances
06/08/1995WO1995015083A1 Bactericidal composition
06/08/1995WO1995013071A3 Treatment of immunoregulatory disorders
06/08/1995DE4421433C1 Transdermal therapeutic system for treatment of, e.g., hypertension
06/08/1995DE4407484A1 Cancer medicament for parenteral admin.
06/08/1995DE4341478A1 Antitumour compsn. comprising starch particles, cytostatic and contrast agent
06/08/1995DE4339080A1 Compsns. for long-term therapy of cardiovascular disorders
06/08/1995CA2617836A1 Nucleosides and oligonucleotides containing boron clusters
06/08/1995CA2604073A1 Poly-.beta.-1.fwdarw.4-n-acetylglucosamine
06/08/1995CA2372026A1 Poly-beta-1->4-n-acetylglucosamine
06/08/1995CA2277954A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
06/08/1995CA2276946A1 Substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions containing the same
06/08/1995CA2178066A1 Dp-iv-serine protease inhibitors
06/08/1995CA2178000A1 Substituted aminoalkylaminopyridines
06/08/1995CA2177998A1 In utero gene therapy for fetuses
06/08/1995CA2177994A1 Tachykinin antagonists
06/08/1995CA2177991A1 A 46 kd human milk fat globule antigen
06/08/1995CA2177978A1 Medicament for treating heart insufficiency
06/08/1995CA2177966A1 Inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient
06/08/1995CA2177848A1 Use of aldosterone antagonists to inhibit myocardial fibrosis
06/08/1995CA2177824A1 1,5-diphenyl pyrazole compounds for treatment of inflammation
06/08/1995CA2177822A1 Administration of a 27-hydroxycholesterol or related compound or sterol-27-hydroxylase stimulant to prevent restenosis following vascular endothelial injuri
06/08/1995CA2177721A1 Taste masked composition containing a drug/polymer complex
06/08/1995CA2177699A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
06/08/1995CA2177574A1 1,3,5-trisubstituted pyrazole compounds for treatment of inflammation
06/08/1995CA2177573A1 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders
06/08/1995CA2177570A1 Method of treating intestinal disorders
06/08/1995CA2177252A1 Human mutator gene hmsh2 and hereditary non polyposis colorectal cancer
06/08/1995CA2177031A1 Inhibition of dna methyltransferase
06/07/1995EP0656364A1 Erythromycin derivatives, their process of preparation and their use as medicaments
06/07/1995EP0656362A1 Novel compounds
06/07/1995EP0656361A1 Immunosuppressive agent
06/07/1995EP0656360A1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same
06/07/1995EP0656359A1 Substituted 6,11-ethano-6,11-dihydrobenzo[b]quinolizinium salts and compositionsand methods of use thereof
06/07/1995EP0656354A1 Substituted N-piperidino 3-pyrazolecarboxamide
06/07/1995EP0656353A1 Aminochinoline derivates useful in the treatment of malaria
06/07/1995EP0656348A2 Aceric acid derivatives as medicaments
06/07/1995EP0656345A1 Aspartic acid derivatives or homologues thereof and their use in the treatment of neurological diseases
06/07/1995EP0656213A1 Treatment of conditions and disease
06/07/1995EP0656211A1 Stable lyophilized thiotepa composition
06/07/1995EP0656210A1 Imidazole derivatives as glutaminose inhibitors
06/07/1995EP0656209A2 Melatonin derivatives for use in treating desynchronization disorders
06/07/1995EP0656208A2 Use of synthetic huminates for the manufacture of a medicament for the treatment of disease of the mucosa
06/07/1995EP0656207A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656206A1 Non-chlorofluorocarbon aerosol formulations
06/07/1995EP0656205A1 Non-chloroflurocarbon aerosol formulations
06/07/1995EP0656201A1 Use of stimulators of glutathione synthesis as hait growth promotors
06/07/1995EP0656178A2 Nutritional compositions for management of nitrogen metabolism
06/07/1995EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates
06/07/1995EP0656037A1 Metal-mediated cross-coupling with ring-metalated porphyrins
06/07/1995EP0656029A1 Crosslinked polymeric ammonium salts
06/07/1995EP0656015A1 New nimesulide salt cyclodextrin inclusion complexes
06/07/1995EP0656009A1 Glycyl-hystidyle-lysine (ghl) derivatives
06/07/1995EP0656007A1 Opioid receptor genes
06/07/1995EP0656003A1 Condensed indole derivatives as 5ht2c and 5ht2b antagonists
06/07/1995EP0656002A1 3-oxo-pyrido(1,2-a -)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a -)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders
06/07/1995EP0656001A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
06/07/1995EP0655996A1 Substituted benzylamino nitrogen containing non-aromatic heterocycles
06/07/1995EP0655928A1 Use of an homeopathic product for the manufacture of a medicament for treatment of metabolic diseases
06/07/1995EP0655926A1 New tumor diagnosing or therapeutical probe
06/07/1995EP0655925A1 Anti-cancer therapeutic compositions containing whey protein concentrate
06/07/1995EP0655923A1 Antiangiogenic oligomers
06/07/1995EP0655921A1 Novel glucan preparation
06/07/1995EP0655920A1 Astragalus polysaccharide immunomodulators
06/07/1995EP0655919A1 Treatment of human viral infections
06/07/1995EP0655918A1 Treatment of cancer with azt and alkylating or intercalating agents
06/07/1995EP0655917A1 Crystalline amifostine compositions and methods for the preparation and use of same
06/07/1995EP0655916A1 Transdermal application agent containing 3-keto-desogestrel
06/07/1995EP0655915A1 Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
06/07/1995EP0655914A1 Novel compositions
06/07/1995EP0655913A1 Novel metallocenes as anti-tumor drugs
06/07/1995EP0655912A1 Medicaments for the treatment or prevention of elevated intraocular pressure
06/07/1995EP0655911A1 Ophthalmological preparation
06/07/1995EP0655907A1 Use of diacylolycerols for increasing the melanin content in melanocytes
06/07/1995EP0616532A4 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease.
06/07/1995EP0608308A4 Anti-seborrhoeic formulation.
06/07/1995EP0454783B1 Site specific in-vivo activation of therapeutic drugs
06/07/1995CN1103533A Biologically active ureido derivatives useful as antimetastatic agents
06/07/1995CN1103402A Substituted pyrroles
06/07/1995CN1103401A Production of pyrrolopyrimidines and intermadiates therefor
1 ... 7012 7013 7014 7015 7016 7017 7018 7019 7020 7021 7022 7023 7024 7025 7026 7027 7028 7029 7030 7031 7032 ... 7860